Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis.

Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS.

J Natl Cancer Inst. 2006 Jun 7;98(11):748-56.

PMID:
16757699
2.

Prevalence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs.

Remaley AT, Sampson ML, DeLeo JM, Remaley NA, Farsi BD, Zweig MH.

Clin Chem. 1999 Jul;45(7):934-41.

3.

Linear regression estimation of minimal detectable concentration. Thyrotropin as an example.

Zweig MH, Kroll MH.

Arch Pathol Lab Med. 1997 Sep;121(9):948-55.

PMID:
9302926
4.

Analytical interference caused by incompletely clotted serum specimens.

Zweig MH, Glickman J, Csako G.

Clin Chem. 1994 Dec;40(12):2325-6. No abstract available.

6.

ROC plots display test accuracy, but are still limited by the study design.

Zweig MH.

Clin Chem. 1993 Jun;39(6):1345-6. No abstract available.

7.

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Zweig MH, Campbell G.

Clin Chem. 1993 Apr;39(4):561-77. Review. Erratum in: Clin Chem 1993 Aug;39(8):1589.

8.
10.

Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome.

Flack MR, Oldfield EH, Cutler GB Jr, Zweig MH, Malley JD, Chrousos GP, Loriaux DL, Nieman LK.

Ann Intern Med. 1992 Feb 1;116(3):211-7.

PMID:
1728204
11.

Inefficiency of diagnostic efficiency.

Zweig MH.

Clin Chem. 1992 Jan;38(1):163-4. No abstract available.

12.

Thyroid dysfunction associated with immunotherapy for patients with cancer.

Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA.

Cancer. 1991 Dec 1;68(11):2384-90.

PMID:
1933775
13.

Interference by iatrogenically induced anti-mouse IgG antibodies in a two-site immunometric assay for thyrotropin.

Zweig MH, Csako G, Reynolds JC, Carrasquillo JA.

Arch Pathol Lab Med. 1991 Feb;115(2):164-8.

PMID:
1992984
14.

High-dose hook effect in a two-site IRMA for measuring thyrotropin.

Zweig MH, Csako G.

Ann Clin Biochem. 1990 Sep;27 ( Pt 5):494-5. No abstract available.

PMID:
2281931
17.

Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. I. Effect of free fatty acids.

Csako G, Zweig MH, Glickman J, Kestner J, Ruddel M.

Clin Chem. 1989 Jan;35(1):102-9. Erratum in: Clin Chem 1989 Nov;35(11):2257.

18.
20.

Evaluation of the clinical accuracy of laboratory tests.

Zweig MH.

Arch Pathol Lab Med. 1988 Apr;112(4):383-6.

PMID:
3355338
21.
22.
23.

Design of protocols to evaluate the efficacy of allergenic extracts and allergy tests.

Zweig MH.

Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1987;(80):239-49. No abstract available.

PMID:
3688866
24.
25.

Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.

Zeltzer PM, Schneider SL, Marangos PJ, Zweig MH.

J Natl Cancer Inst. 1986 Sep;77(3):625-31.

PMID:
3462406
26.
27.

On the albumin dependence of measurements of free thyroxin. I. Technical performance of seven methods.

Csako G, Zweig MH, Benson C, Ruddel M.

Clin Chem. 1986 Jan;32(1 Pt 1):108-15.

29.

Establishment and identification of small cell lung cancer cell lines having classic and variant features.

Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD.

Cancer Res. 1985 Jun;45(6):2913-23.

30.

Expression of peptide and other markers in lung cancer cell lines.

Gazdar AF, Carney DN, Becker KL, Deftos LJ, Liang V, Go W, Marangos PJ, Moody TW, Wolfsen AR, Zweig MH.

Recent Results Cancer Res. 1985;99:167-74. No abstract available.

PMID:
2999915
31.

Elevated serum creatine kinase BB levels in patients with small cell lung cancer.

Carney DN, Zweig MH, Ihde DC, Cohen MH, Makuch RW, Gazdar AF.

Cancer Res. 1984 Nov;44(11):5399-403.

32.

Evaluating the clinical efficacy of laboratory tests.

Robertson EA, Zweig MH, Van Steirteghem AC.

Am J Clin Pathol. 1983 Jan;79(1):78-86. No abstract available.

PMID:
6849296
33.

Comparison of the effectiveness of four clinical chemical assays in classifying patients with chest pain.

Van Steirteghem AC, Zweig MH, Robertson EA, Bernard RM, Putzeys GA, Bieva CJ.

Clin Chem. 1982 Jun;28(6):1319-24.

34.

Why we need better test evaluations.

Zweig MH, Robertson EA.

Clin Chem. 1982 Jun;28(6):1272-6.

35.

Evaluation of thyroid status.

Zweig MH.

JAMA. 1982 Apr 23;247(16):2231-2. No abstract available.

PMID:
7069871
36.

Creatine kinase isozymes in the serum and CSF of schizophrenic patients.

Zweig MH, Van Steirteghem AC, Torrey EF.

Arch Gen Psychiatry. 1981 Oct;38(10):1107-9.

PMID:
7294965
37.
38.

Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures.

Gazdar AF, Zweig MH, Carney DN, Van Steirteghen AC, Baylin SB, Minna JD.

Cancer Res. 1981 Jul;41(7):2773-7.

40.

Creatine kinase isoenzyme BB concentration in serum as a marker of myocardial infarction.

Van Steirteghem AC, Zweig MH, Bernard RM, Putzeys GA, Bieva CJ.

Clin Chem. 1980 Jun;26(7):1110. No abstract available.

PMID:
7379300
41.

Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.

Zweig MH, Adornato B, Van Steirteghem AC, Engel WK.

Ann Neurol. 1980 Apr;7(4):324-8.

PMID:
7377757
42.

Lot-to-lot variation in three thyroid-related radioimmunoassay kits.

Zweig MH, Robertson EA.

Clin Chem. 1980 Apr;26(5):646-8.

43.

The presence of creatine kinase BB isoenzyme in patients with prostatic cancer.

Feld RD, van Steirteghem AC, Zweig MH, Weimar GW, Narayana AS, Witte DL.

Clin Chim Acta. 1980 Jan 31;100(3):267-73.

PMID:
7353312
44.

Creatine kinase BB: a new tumor-associated marker.

Silverman LM, Dermer GB, Zweig MH, Van Steirteghem AC, Tökés ZA.

Clin Chem. 1979 Aug;25(8):1432-5.

45.

Serum creatine kinase isoenzyme BB as an indicator of active metastatic disease.

Zweig MH, Silverman LM, Dermer GB, Van Steirteghen AC.

Clin Chem. 1979 Jun;25(6):1190-1. No abstract available.

46.

Increased CK-BB concentrations in serum following cardiac surgery.

Zweig MH, Van Steirteghem AC.

Clin Chim Acta. 1979 Apr 2;93(1):29-33.

PMID:
436298
47.

Distribution of serum concentrations of creatine kinase MM and BB isoenzymes measured by radioimmunoassay.

Van Steirteghem AC, Robertson EA, Zweig MH.

Clin Chim Acta. 1979 Apr 2;93(1):25-8.

PMID:
436297
48.

Creatine kinase isoenzyme BB increases in serum after cardiac surgery.

Zweig MH, Van Steirteghem AC.

Clin Chem. 1978 Oct;24(10):1853. No abstract available.

PMID:
699308
49.

Radioimmunoassay of creatine kinase isoenzymes in human serum: isoenzyme BB.

Zweig MH, Van Steirteghem AC, Schechter AN.

Clin Chem. 1978 Mar;24(3):422-8.

50.

Radioimmunoassay of creatine kinase isoenzymes in human serum: isoenzyme MM.

Van Steirteghem AC, Zweig MH, Schechter AN.

Clin Chem. 1978 Mar;24(3):414-9.

Supplemental Content

Loading ...
Support Center